Netarsudil Drops After Retinal Detachment Surgery
Part of Eyes & vision clinical trials.
This study tests whether netarsudil eye drops can prevent vision-threatening scar tissue (proliferative vitreoretinopathy) after retinal detachment repair. If you are having surgery for a retinal detachment, these drops may reduce the risk of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a retinal detachment that needs surgery within 28 days of symptoms starting
- You are having vitrectomy (removal of gel inside eye) with or without a scleral buckle
- You have not had prior glaucoma surgery or used netarsudil drops in the affected eye
- You do not have active eye infections, severe inflammatory eye disease, or diabetic eye disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of surgery for people with a retinal detachment who still have their natural lens (no prior cataract surgery). One group gets vitrectomy alone; the other gets vitrectomy plus the lens removed at the same time. The goal is to see which approach leads to better outcomes.
This study compares two types of surgery for retinal detachment that is more complex—when there are large or multiple holes. One surgery uses a flexible band around the eye, the other removes the gel inside the eye. The goal is to see which works better for medium-complex cases.
This study uses special imaging to see how the eye-pressure-lowering medication netarsudil (Rhopressa) works on the part of your eye that drains fluid. Researchers want to understand whether it helps restore normal drainage in people with high eye pressure or glaucoma.
This trial tests if taking a daily supplement called nicotinamide riboside after retinal detachment surgery can help the eye heal better and see more clearly. It is for people who had a specific type of retinal detachment and have already had cataract surgery.
This Phase 2 trial tests an injection of topotecan into the eye after surgery for retinal detachment that keeps coming back due to scar tissue (proliferative vitreoretinopathy). It may help improve how the retina heals after difficult, repeat operations when vision is usually very guarded.
This trial tests if adding ursodeoxycholic acid (a bile acid medication) to standard surgery can protect the retina and improve vision after a retinal detachment. It's for people who need vitrectomy surgery and have a detached retina involving the macula.
Hear when a new Rhegmatogenous Retinal Detachment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.